Bedier H, Isnard S, Maedler-Kron C, Routy J-P. Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19. EJCRIM [Internet]. 2023 Nov. 17 [cited 2026 Nov. 3];10(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4098